Immediate Sequential Bilateral Implantable Collamer Lens Surgery Is Safe and Effective.

IF 3 3区医学 Q1 OPHTHALMOLOGY Journal of refractive surgery Pub Date : 2024-05-01 DOI:10.3928/1081597X-20240326-01

Andrea Russo, Ottavia Filini, Erik Mertens, Sheraz M Daya, Luigi Conti, Francesco Carones, Giulia Festa, Alessandro Boldini, Giacomo Savini

{"title":"Immediate Sequential Bilateral Implantable Collamer Lens Surgery Is Safe and Effective.","authors":"Andrea Russo, Ottavia Filini, Erik Mertens, Sheraz M Daya, Luigi Conti, Francesco Carones, Giulia Festa, Alessandro Boldini, Giacomo Savini","doi":"10.3928/1081597X-20240326-01","DOIUrl":null,"url":null,"abstract":"Purpose: To assess the clinical outcomes and safety profiles of patients who underwent immediate sequential bilateral phakic lens surgery.Methods: This retrospective multicenter study included 254 consecutive patients (508 eyes) who underwent bilateral same-day Implantable Collamer Lens (ICL) (STAAR Surgical) surgery. The authors focused on 1-year postoperative clinical outcomes and adverse events.Results: In the initial cohort, 176 patients (352 eyes) met inclusion criteria. Of these, 335 eyes underwent myopic ICL placement, and 17 eyes received a hyperopic ICL. Notably, 87% of eyes achieved ±0.50 diopters (D) and 95% achieved ±1.00 D of the intended refraction. One year postoperatively, 78% of eyes demonstrated optimal vaulting (250 to 750 µm), with a significant 19% reduction in vaulting observed over the 12 months (P < .001). Only minor adverse events, including early cataract formation (1 case), secondary toric ICL rotation (3 cases), and ICL exchange due to inappropriate vaulting (6 cases), were noted.Conclusions: The findings corroborate the safety and efficacy of immediate sequential bilateral phakic lens surgery and indicate its potential as a treatment option. The low incidence of minor adverse events further reinforces its favorable safety profile. [J Refract Surg. 2024;40(5):e313-e320.].","PeriodicalId":16951,"journal":{"name":"Journal of refractive surgery","volume":"40 5","pages":"e313-e320"},"PeriodicalIF":3.0000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/1081597X-20240326-01","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To assess the clinical outcomes and safety profiles of patients who underwent immediate sequential bilateral phakic lens surgery.

Methods: This retrospective multicenter study included 254 consecutive patients (508 eyes) who underwent bilateral same-day Implantable Collamer Lens (ICL) (STAAR Surgical) surgery. The authors focused on 1-year postoperative clinical outcomes and adverse events.

Results: In the initial cohort, 176 patients (352 eyes) met inclusion criteria. Of these, 335 eyes underwent myopic ICL placement, and 17 eyes received a hyperopic ICL. Notably, 87% of eyes achieved ±0.50 diopters (D) and 95% achieved ±1.00 D of the intended refraction. One year postoperatively, 78% of eyes demonstrated optimal vaulting (250 to 750 µm), with a significant 19% reduction in vaulting observed over the 12 months (P < .001). Only minor adverse events, including early cataract formation (1 case), secondary toric ICL rotation (3 cases), and ICL exchange due to inappropriate vaulting (6 cases), were noted.

Conclusions: The findings corroborate the safety and efficacy of immediate sequential bilateral phakic lens surgery and indicate its potential as a treatment option. The low incidence of minor adverse events further reinforces its favorable safety profile. [J Refract Surg. 2024;40(5):e313-e320.].

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

即刻顺序双侧可植入式人工晶体手术安全有效。

目的：评估接受即刻顺序双侧人工晶体手术患者的临床疗效和安全性：这项回顾性多中心研究共纳入了 254 名连续患者（508 只眼），他们都在当天接受了双侧可植入式有晶体眼人工晶体（ICL）（STAAR Surgical）手术。作者重点研究了术后 1 年的临床结果和不良事件：在初始队列中，有 176 名患者（352 只眼）符合纳入标准。其中 335 只眼睛接受了近视 ICL 植入术，17 只眼睛接受了远视 ICL 植入术。值得注意的是，87%的眼睛达到了±0.50屈光度（D），95%的眼睛达到了±1.00屈光度。术后一年，78% 的眼睛显示出最佳穹隆度（250 至 750 微米），12 个月内穹隆度显著降低了 19%（P < .001）。仅出现了轻微的不良反应，包括早期白内障形成（1 例）、继发性散光 ICL 旋转（3 例）以及因穹窿不合适而更换 ICL（6 例）：结论：研究结果证实了即刻双侧相控阵晶状体手术的安全性和有效性，并显示了其作为一种治疗方案的潜力。轻微不良反应发生率低，进一步巩固了其良好的安全性。[J Refract Surg. 2024;40(5):e313-e320.].

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

$Journal of refractive surgery$

Journal of refractive surgery 医学-外科

CiteScore

5.10

自引率

12.50%

发文量

160

审稿时长

4-8 weeks

期刊介绍： The Journal of Refractive Surgery, the official journal of the International Society of Refractive Surgery, a partner of the American Academy of Ophthalmology, has been a monthly peer-reviewed forum for original research, review, and evaluation of refractive and lens-based surgical procedures for more than 30 years. Practical, clinically valuable articles provide readers with the most up-to-date information regarding advances in the field of refractive surgery. Begin to explore the Journal and all of its great benefits such as: • Columns including “Translational Science,” “Surgical Techniques,” and “Biomechanics” • Supplemental videos and materials available for many articles • Access to current articles, as well as several years of archived content • Articles posted online just 2 months after acceptance.